Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
28,82 USD | +3,33 % | +4,91 % | +265,27 % |
Métier
Nombre d'employés: 45
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Ronald Martell
CEO | Chief Executive Officer | 62 | 15/03/22 |
Herbert Cross
DFI | Director of Finance/CFO | 52 | 22/09/23 |
Luca Di Noto
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/20 |
Wendy Pang
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/20 |
Edwin Tucker
CTO | Chief Tech/Sci/R&D Officer | 52 | 12/06/23 |
Jeet Mahal
COO | Chief Operating Officer | 52 | 01/12/19 |
Matthew Ford
HRO | Human Resources Officer | - | 13/04/23 |
David Hinds
PRN | Corporate Officer/Principal | - | 10/04/23 |
Patricia Carlos
LAW | General Counsel | - | 02/08/23 |
Arjun Agarwal
AUD | Comptroller/Controller/Auditor | - | 01/01/21 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Ronald Martell
CEO | Chief Executive Officer | 62 | 15/03/22 |
Thomas Wiggans
CHM | Chairman | 72 | 01/11 |
Kurt von Emster
BRD | Director/Board Member | 56 | 24/09/21 |
Scott Brun
BRD | Director/Board Member | 56 | 20/06/23 |
Vishal Kapoor
BRD | Director/Board Member | 48 | 16/02/23 |
Christian Nolet
BRD | Director/Board Member | 67 | 24/09/21 |
Anna Phil
BRD | Director/Board Member | 36 | 24/09/19 |
Judith Shizuru
FOU | Founder | 68 | 01/03/18 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 15 063 896 | 13 892 140 ( 92,22 %) | 0 | 92,22 % |
Coordonnées société
Jasper Therapeutics, Inc.
2200 Bridge Parkway Suite 102
94065, Redwood City
+
http://www.jaspertherapeutics.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+265,27 % | 434 M | |
+33,50 % | 701 Md | |
+26,24 % | 571 Md | |
+0,78 % | 381 Md | |
+20,85 % | 334 Md | |
+16,38 % | 319 Md | |
+2,91 % | 210 Md | |
+1,68 % | 210 Md | |
-6,91 % | 201 Md | |
-3,51 % | 157 Md |
- Bourse
- Actions
- Action Jasper Therapeutics, Inc. - Nasdaq
- Société Jasper Therapeutics, Inc.